beta-alanine has been researched along with Obesity in 7 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report intermittent seizures, lethargy, and Cohen's syndrome in a 4-year-old girl with hyper-beta-alaninemia and a partial deficiency of beta-alanyl-alpha-ketoglutarate transaminase (AKT)." | 7.69 | Pyridoxine-responsive hyper-beta-alaninemia associated with Cohen's syndrome. ( Barton, NW; Bernardini, I; Brady, RO; Higgins, JJ; Kaneski, CR, 1994) |
| "Three pivotal phase 3 trials have demonstrated that oral dabigatran etexilate showed similar safety and efficacy to enoxaparin 40 mg once daily (qd) for venous thromboembolism (VTE) prevention in patients undergoing total knee or hip replacement." | 3.78 | Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis. ( Clemens, A; Dahl, OE; Eriksson, BI; Feuring, M; Friedman, RJ; Hantel, S; Huo, M; Noack, H, 2012) |
| "We report intermittent seizures, lethargy, and Cohen's syndrome in a 4-year-old girl with hyper-beta-alaninemia and a partial deficiency of beta-alanyl-alpha-ketoglutarate transaminase (AKT)." | 3.69 | Pyridoxine-responsive hyper-beta-alaninemia associated with Cohen's syndrome. ( Barton, NW; Bernardini, I; Brady, RO; Higgins, JJ; Kaneski, CR, 1994) |
| " Clinicians are increasingly being challenged with making uncertain anticoagulant dosing decisions, as the optimal dosing strategy for most anticoagulants in the obese patient population remains unknown." | 2.47 | Anticoagulating obese patients in the modern era. ( Arya, R; Patel, JP; Roberts, LN, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breuer, L | 1 |
| Ringwald, J | 1 |
| Schwab, S | 1 |
| Köhrmann, M | 1 |
| Prandoni, P | 1 |
| Barbar, S | 1 |
| Milan, M | 1 |
| Vedovetto, V | 1 |
| Pesavento, R | 1 |
| You, JS | 1 |
| Lee, YJ | 1 |
| Kim, SY | 1 |
| Kim, SH | 1 |
| Chang, KJ | 1 |
| Pelantová, H | 1 |
| Bugáňová, M | 1 |
| Holubová, M | 1 |
| Šedivá, B | 1 |
| Zemenová, J | 1 |
| Sýkora, D | 1 |
| Kaválková, P | 1 |
| Haluzík, M | 1 |
| Železná, B | 1 |
| Maletínská, L | 1 |
| Kuneš, J | 1 |
| Kuzma, M | 1 |
| Patel, JP | 1 |
| Roberts, LN | 1 |
| Arya, R | 1 |
| Eriksson, BI | 1 |
| Dahl, OE | 1 |
| Feuring, M | 1 |
| Clemens, A | 1 |
| Noack, H | 1 |
| Hantel, S | 1 |
| Friedman, RJ | 1 |
| Huo, M | 1 |
| Higgins, JJ | 1 |
| Kaneski, CR | 1 |
| Bernardini, I | 1 |
| Brady, RO | 1 |
| Barton, NW | 1 |
2 reviews available for beta-alanine and Obesity
| Article | Year |
|---|---|
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; | 2014 |
Anticoagulating obese patients in the modern era.
Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dab | 2011 |
5 other studies available for beta-alanine and Obesity
| Article | Year |
|---|---|
Ischemic stroke in an obese patient receiving dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Male; Middle Aged; Obesity; Proton | 2013 |
Anti-obesity and Hypolipidemic Effects of N-(β-D-Xylopyranosyl) Taurine Sodium Salt Supplementation in Rats Fed a High-Fat Diet and β-Alanine.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; beta-Alanine; Body Weight; Diet, High-Fat; Drinking; E | 2015 |
Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.
Topics: Adamantane; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Diet; Glucose Tolerance Test; Hypoglyc | 2016 |
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; | 2012 |
Pyridoxine-responsive hyper-beta-alaninemia associated with Cohen's syndrome.
Topics: 4-Aminobutyrate Transaminase; Abnormalities, Multiple; beta-Alanine; Child; Female; Humans; Intellec | 1994 |